PHAT Phathom Pharmaceuticals Inc

USD 18.94 +0.67 ( +3.67)%
Icon

Phathom Pharmaceuticals Inc (PHAT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 18.94

+0.67 (+3.67)%

N/A

1.17M

USD 25.33(+33.76%)

USD 17.50 (-7.60%)

Icon

PHAT

Phathom Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 18.94
+0.67 ( +3.67)%

ETFs Holding Phathom Pharmaceuticals Inc (PHAT)

Symbol Name Exchange PHAT's Weight Expense Ratio Price(Change) Market Cap
BBP
Virtus LifeSci Biotech Pr.. NYE 2.29 % 0.79 % -0.26 (-0.40%) USD0.02B

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...